ATH 25.0% 0.3¢ alterity therapeutics limited

4. start of new thread. 4, page-95

  1. 22,691 Posts.
    re: 4. annual report. 4
    25 Aug:
    http://stocknessmonster.com/news-item?S=PBT&E=ASX&N=223248

    Sept 14: Annual Report:
    http://stocknessmonster.com/news-item?S=PBT&E=ASX&N=224255

    Extract:
    " We also believe that PBT-1 has the potential to be approved as a therapy in its own right. The
    further clinical development of PBT-1 is now being considered".

    "We are now concentrating on developing new and
    superior MPACs : PBT-2 has since demonstrated superior performance across a range of in vitro and in vivo preclinical tests and is in the final months of toxicology testing before entering clinical trials early in 2005".

    Oct. 6: Dr Bush awarded 2004 Zenith Fellow Award for Research:
    http://stocknessmonster.com/news-item?S=PBT&E=ASX&N=225479



 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.